The emergence of the BA.3.2 strain comes amid broader uneasiness about COVID vaccination rates among seniors, who are ...
By Julie Steenhuysen CHICAGO, April 21 (Reuters) - Americans may face the next respiratory disease season without clear ...
Some of the newer COVID-19 variants (like Cicada COVID or BA.3.2) cause razor-like throat pain, but so do other illnesses.
April 21 () - Moderna said on Tuesday the European Commission had granted marketing authorization for a combination ...
The COVID-19 variant BA.3.2, nicknamed "Cicada," has been detected in at least 23 countries and half the states in the U.S.
Results from a small randomized controlled clinical trial show promising findings about a new type of therapy for patients ...
COMBRIAX is the world's first flu plus COVID combination vaccine to receive marketing authorization and Moderna's ...
The experimental evidence on using hyperbaric oxygen in people with persistent COVID symptoms appeared to be promising, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results